Ibritumomab tiuxetan (90y)

Zevalin

Kit per preparazione radiofarmaceuticaItalyAuthorised

In other countries

The same active substances on other registers, the same brand first.

ZevalinCanada · 3.2 MG / 2 ML · Kit, Solution · Auro Pharma INCSame brand
ZEVALIN 1,6 mg/ml, EQUIPO REACTIVO PARA LA PREPARACION DE UN RADIOFARMACO PARA PERFUSIONSpain · 1,6 mg · equipo de reactivos para preparación radiofarmacéutica · Ceft Biopharma S.R.O.Same brand
ZevalinEuropean Union · Ceft Biopharma s.r.o.Same brand
ZevalinCroatiaSame brand
ZevalinUnited States · 3.2MG/2ML · injectable · Spectrum PharmsSame brand

Packs

Pack	Code	Status
1,6 MG/ML KIT PER PREPARAZIONE RADIOFARMACEUTICA PER INFUSIONE 1 FLACONCINO 2 ML USO ENDOVENOSO	036311013	Autorizzata

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ibritumomab tiuxetan (90y)

Zevalin

Kit per preparazione radiofarmaceuticaItalyAuthorised

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
1,6 MG/ML KIT PER PREPARAZIONE RADIOFARMACEUTICA PER INFUSIONE 1 FLACONCINO 2 ML USO ENDOVENOSO	036311013	Autorizzata

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ibritumomab tiuxetan (90y)
Dosage form: Kit per preparazione radiofarmaceutica
Register: Italy (AIFA)
Status: Authorised
Status in the register: Autorizzata
Registration: AIC 036311
Marketing authorisation holder: Ceft Biopharma S.R.O.
ATC code: V10XX02
Group: Various
Procedure: Procedura Centralizzata
Supply: Medicinali soggetti a prescrizione medica limitativa, utilizzabili esclusivamente in ambiente ospedaliero o in una struttura ad esso assimilabile